These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16443769)

  • 1. Angiotensin II type 1 receptor blockade improves beta-cell function and glucose tolerance in a mouse model of type 2 diabetes.
    Chu KY; Lau T; Carlsson PO; Leung PS
    Diabetes; 2006 Feb; 55(2):367-74. PubMed ID: 16443769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice.
    Chu KY; Leung PS
    Antioxid Redox Signal; 2007 Jul; 9(7):869-78. PubMed ID: 17508912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets.
    Lau T; Carlsson PO; Leung PS
    Diabetologia; 2004 Feb; 47(2):240-8. PubMed ID: 14722647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor inhibition markedly improves the blood perfusion, oxygen tension and first phase of glucose-stimulated insulin secretion in revascularised syngeneic mouse islet grafts.
    Kampf C; Lau T; Olsson R; Leung PS; Carlsson PO
    Diabetologia; 2005 Jun; 48(6):1159-67. PubMed ID: 15877216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway.
    Madec AM; Cassel R; Dubois S; Ducreux S; Vial G; Chauvin MA; Mesnier A; Chikh K; Bosco D; Rieusset J; Van Coppenolle F; Thivolet C
    FASEB J; 2013 Dec; 27(12):5122-30. PubMed ID: 24008754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice.
    Nagata T; Fukuzawa T; Takeda M; Fukazawa M; Mori T; Nihei T; Honda K; Suzuki Y; Kawabe Y
    Br J Pharmacol; 2013 Oct; 170(3):519-31. PubMed ID: 23751087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of small interfering RNA-mediated angiotensin II type 1 receptor knockdown on first-phase insulin secretion in isolated diabetic rat islets].
    Yi Q; Liu Y; Zhang Z; Liu C; Lu B; Shao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):671-6. PubMed ID: 26018260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hyperglycemia on angiotensin II receptor type 1 expression and insulin secretion in an INS-1E pancreatic beta-cell line.
    Leung KK; Leung PS
    JOP; 2008 May; 9(3):290-9. PubMed ID: 18469441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes.
    Cheng Q; Law PK; de Gasparo M; Leung PS
    J Pharmacol Exp Ther; 2008 Dec; 327(3):683-91. PubMed ID: 18787107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in
    Kang T; Boland BB; Jensen P; Alarcon C; Nawrocki A; Grimsby JS; Rhodes CJ; Larsen MR
    Mol Cell Proteomics; 2020 Jun; 19(6):971-993. PubMed ID: 32265294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
    Chipitsyna G; Gong Q; Gray CF; Haroon Y; Kamer E; Arafat HA
    Endocrinology; 2007 May; 148(5):2198-208. PubMed ID: 17303665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of angiotensin II type 1 receptor blocker on islet of diabetic db/db mice].
    Shao JQ; Iwashita N; Du H; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):306-10. PubMed ID: 17637271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.
    Husarek KE; Katz PS; Trask AJ; Galantowicz ML; Cismowski MJ; Lucchesi PA
    Vascul Pharmacol; 2016 Jan; 76():28-36. PubMed ID: 26133668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blocker provides pancreatic beta-cell protection independent of blood pressure lowering in diabetic db/db mice.
    Shao JQ; Iwashita N; Du H; Wang YT; Wang YY; Zhao M; Wang J; Watada H; Kawamori R
    Acta Pharmacol Sin; 2007 Feb; 28(2):246-57. PubMed ID: 17241528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Analysis of Restored Insulin Production and Trafficking in Obese Diabetic Mouse Pancreatic Islets Following Euglycemia.
    Kang T; Boland BB; Alarcon C; Grimsby JS; Rhodes CJ; Larsen MR
    J Proteome Res; 2019 Sep; 18(9):3245-3258. PubMed ID: 31317746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice.
    Shao J; Iwashita N; Ikeda F; Ogihara T; Uchida T; Shimizu T; Uchino H; Hirose T; Kawamori R; Watada H
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1224-33. PubMed ID: 16650382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic beta-cells via angiotensin II type 2 receptors.
    Chu KY; Cheng Q; Chen C; Au LS; Seto SW; Tuo Y; Motin L; Kwan YW; Leung PS
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C313-23. PubMed ID: 19889960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R.
    Wang XP; Zhang R; Wu K; Wu L; Dong Y
    Pancreas; 2004 Nov; 29(4):264-70. PubMed ID: 15502641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
    Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.